Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise. CISCO-21

Authors: Morrow, Andrew J.;

Gray, Stuart R.;

Bayes, Hannah K.;

Sykes, Robert;

McGarry, E.;

Anderson, David;

Boiskin, D.;

Burke, C.;

Cleland, John G.F. ;

Goodyear, Carl S.;

Ibbotson, Tracy R.;

Lang, Chim C. ;

McConnachie, Alex;

Mair, Frances S.;

Mangion, Kenneth;

Patel, Manish;

Sattar, Naveed ;

Taggart, Diann;

Taylor, R.;

Dawkes, Susan;

Berry, Colin

Source: Trials

Full text

: https://dx.doi.org/10.1186/s13063-022-06632-y

Abstract

Background: Coronavirus disease-19 (COVID-19) infection causes persistent health problems such as breathlessness, chest pain and fatigue, and therapies for the prevention and early treatment of post-COVID-19 syndromes are needed. Accordingly, we are investigating the effect of a resistance exercise intervention on exercise capacity and health status following COVID-19 infection.

Methods: A two-arm randomised, controlled clinical trial including 220 adults with a diagnosis of COVID-19 in the preceding 6 months. Participants will be classified according to clinical presentation: Group A, not hospitalised due to COVID but persisting symptoms for at least 4 weeks leading to medical review; Group B, discharged after an admission for COVID and with persistent symptoms for at least 4 weeks; or Group C, convalescing in hospital after an admission for COVID.

Participants will be randomised to usual care or usual care plus a personalised and pragmatic resistance exercise intervention for 12 weeks. The primary outcome is the incremental shuttle walks test (ISWT) 3 months after randomisation with secondary outcomes including spirometry, grip strength, short performance physical battery (SPPB), frailty status, contacts with healthcare professionals, hospitalisation and questionnaires assessing health-related quality of life, physical activity, fatigue and dyspnoea.

Discussion: Ethical approval has been granted by the National Health Service (NHS) West of Scotland Research Ethics Committee (REC) (reference: GN20CA537) and recruitment is ongoing. Trial findings will be disseminated through patient and public forums, scientific conferences and journals.

Rights

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Cite as

Morrow, A., Gray, S., Bayes, H., Sykes, R., McGarry, E., Anderson, D., Boiskin, D., Burke, C., Cleland, J., Goodyear, C., Ibbotson, T., Lang, C., McConnachie, A., Mair, F., Mangion, K., Patel, M., Sattar, N., Taggart, D., Taylor, R., Dawkes, S. & Berry, C. 2022, 'Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise. CISCO-21', Trials, 23(1), article no: 660. https://dx.doi.org/10.1186/s13063-022-06632-y

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://dx.doi.org/10.1186/s13063-022-06632-y

Repository URI: http://eprints.gla.ac.uk/276294/